NBC News is launching a twice-per-day news show on Snapchat, the company said on Wednesday, part of its push to attract younger viewers who tend to watch TV on mobile devices. Comcast’s NBCUniversal invested $500 million in Snapchat owner Snap Inc. during its initial public offering as it seeks to boost its digital offering. Broadcast...
invest seek inc.
225 broadway, 39th floor
new york, new york, 10007
NYS Entity Status
NYS Filing Date
APRIL 17, 2014
NYS DOS ID#
NYS Entity Type
DOMESTIC BUSINESS CORPORATION
2014 - INVEST SEEK INC.
AROUND THE WEB
- NBC News to launch daily show on Snapchat
By Reuters - Wednesday Jul 19, 2017
- Food & Wine Magazine Will Leave New York for Alabama
By STEPHANIE STROM - Friday Jun 23, 2017
The move reflects a changing business in which traditional food magazines, and a Manhattan address, are less important.
- News Outlets to Seek Bargaining Rights Against Google and Facebook
By JIM RUTENBERG - Sunday Jul 9, 2017
A group of news organizations plans to ask Congress for the right to negotiate with the online giants, which are gaining greater shares of digital advertising and distribution.
- WPP Invests In Podcaster, Brooklyn-Based Gimlet Part Of Digital Content Play
Thursday Sep 7, 2017
WPP continues to hedge its content bets, announcing a strategic investment this week in promising podcasting company, Gimlet Media Inc. WPP said it is investing $5 million for an undisclosed minoritystake in Gimlet, citing such branded content customers as Alphabet Inc., Ford Motor Co., PepsiCo, Match Group, eBay, Blue Apron, Goldman Sachs and Microsoft. Based in Brooklyn, New York, Gimlet wasfounded in 2014 and has 85 employees. It has raised $27 million in funding to date.
- Taxi Medallions, Once a Safe Investment, Now Drag Owners Into Debt
By WINNIE HU - Sunday Sep 10, 2017
Some taxi owners say they cannot hold on much longer as they lose riders and fares to Uber and other rivals, and their taxi medallions plummet in value.
- Stealthy NY Startup Rocket Pharma Merges With Inotek, Heads to Nasdaq
By Ben Fidler - Tuesday Sep 12, 2017
Rocket Pharmaceuticals, a stealthy gene therapy startup in New York City, has made its first splash. Through a merger with struggling Inotek Pharmaceuticals (NASDAQ: ITEK), Rocket, a company developing treatments for a variety of rare blood diseases, has taken itself public. Rocket shareholders are expected to own 81 percent of the combined company, with Inotek […]